EIF5A2 Expression in human GC tissues and its prognostic significance.

<p>(<b>A</b>) Representative immunohistochemistry images showing EIF5A2 overexpression in moderately-differentiated adenocarcinoma (×200). (<b>B</b>) Overexpression of EIF5A2 in poorly-differentiated gastric adenocarcinoma (×200). (<b>C</b>) Overexpression of EIF5A2 in tumor cells invading vessels (×200). (<b>D</b>) Normal expression of EIF5A2 in non-tumor tissue (×100). (<b>E</b>) The typical staining images showing both EIF5A2 and MTA1 overexpression in the same gastric adenocarcinoma; (<b>G</b>) Overall survival curves for 160 gastric cancer patients receiving gastrectomy, grouped according to EIF5A2 expression (<i>P</i><0.001). (<b>H</b>) Disease-free survival curves for 145 gastric cancer patients receiving curative surgery, grouped according to EIF5A2 expression (<i>P</i> = 0.001).